Evidence map›Paper›PMID 37197783›Full record

ArticleJournal of medical genetics2023

Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in

Amytice Mirchi, Simon-Pierre Guay, Luan T Tran, Nicole I Wolf, Adeline Vanderver, Bernard Brais, Michel Sylvain, Daniela Pohl, Elsa Rossignol, Michael Saito and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Rigorous genetic diagnosis review in natural history studies.Orphanet journal of rare diseases · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Biallelic pathogenic variants inFrontiers in neurology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 12 countries.

Amytice Mirchi *Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-8887-1681
Simon-Pierre Guay *Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Luan T TranDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Nicole I WolfDepartment of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, and Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Vrije Universiteit, Amsterdam, Netherlands.
Adeline VanderverDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Bernard BraisDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Michel SylvainCentre Mère Enfant, CHU de Québec, Québec City, Quebec, Canada.
Daniela PohlDivision of Neurology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
Elsa RossignolDepartments of Neurosciences and Pediatrics, CHU-Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Michael SaitoDepartment of Pediatrics, University of California Riverside School of Medicine, Riverside Medical Clinic, Riverside, California, USA.
Sebastien MouttonCentre Pluridisciplinaire de Diagnostic PréNatal, MSPBordeaux Bagatelle, Talence, France.
Luis González-Gutiérrez-SolanaSección de Neuropediatría, Hospital Infantil Universitario Niño Jesús, Madrid, España; Grupo Clínico Vinculado al Centro de Investigación Biomédica en Red para Enfermedades Raras (CIBERER) GCV14/ER/6, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
Isabelle ThiffaultGenomic Medicine Center, Children's Mercy Hospital, Kansas City, Missouri, USA.
Michael C KruerDepartments of Child Health, Neurology, and Cellular & Molecular Medicine and Program in Genetics, University of Arizona College of Medicine, Phoenix, Arizona, USA.ORCID 0000-0002-1373-7891
Dolores Gonzales MoronNeurogenetics Unit, Department of Neurology, Hospital JM Ramos Mejia, ADC, Buenos Aires, Argentina.
Marcelo KauffmanNeurogenetics Unit, Department of Neurology, Hospital JM Ramos Mejia and CONICET-Universidad Austral, Buenos Aires, Argentina.
Cyril GoizetCentre de Référence Neurogénétique, Service de Génétique Médicale, Bordeaux University Hospital, CHU Bordeaux, Bordeaux, France.
László SztrihaDepartment of Paediatrics, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Emma GlamuzinaAdult and Paediatric National Metabolic Service, Starship Children's Hospital, Auckland, Te Whatu Ora, New Zealand.
Serge B MelançonDepartment of Medical Genetics, McGill University Health Centre, Montreal Children's Hospital, Montreal, Quebec, Canada.
Sakkubai NaiduDepartment of Neurogenetics, Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Jean-Marc RetrouveyDepartment of Orthodontics, University of Missouri, Kansas City, Missouri, USA.
Suzanne LacombeDepartment of Orthodontics, University of Missouri, Kansas City, Missouri, USA.
Beatriz Bernardino-CuestaSección de Neuropediatría, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Isabelle De Bie *Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Geneviève Bernard *Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada genevieve.bernard@mcgill.ca.
McGill University Health Centre · CAUniversity of Missouri–Kansas City · USBarrow Neurological Institute · USCentre for Biomedical Network Research on Rare Diseases · ESCentre hospitalier universitaire de Québec · CACentre Hospitalier Universitaire Sainte-Justine · CACentre National de la Recherche Scientifique · FRChildren's Hospital of Philadelphia · USChildren's Mercy Hospital · USConsejo Nacional de Investigaciones Científicas y Técnicas · AREmma Kinderziekenhuis · NLHospital Infantil Universitario Niño Jesús · ESHospital Ramos Mejía · ARKennedy Krieger Institute · USMontreal Children's Hospital · CAMontreal Neurological Institute and Hospital · CAStarship Children's Health · NZUniversity of California, Riverside · USUniversity of Ottawa · CAUniversity of Szeged · HU

Funding

Validation of the GMFC-MLDU54NS115052 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Adeline Lucie Vanderver · 2019 to 2026
$14.3M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
Clinical Outcomes in Aicardi Goutières SyndromeU01NS106845 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI VANDERVER, ADELINE LUCIE · 2019 to 2023
$7.5M
Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
Genomic analysis of the Multiplex, Autozygous Populations in Cerebral Palsy (MAP CP) cohort: a focused approach to a complex diseaseR01NS127108 · NINDS · UNIVERSITY OF ARIZONA · PI Michael C Kruer · 2023 to 2026
$2.6M
Reverse transcriptase inhibition as a novel therapeutic approach for ADAR-1-related Aicardi Goutières SyndromeR21NS123477 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI VANDERVER, ADELINE LUCIE · 2022 to 2022
$500k
NICHD NIH HHS P50 HD103538NINDS NIH HHS R01 NS106298NINDS NIH HHS R01 NS127108NINDS NIH HHS R21 NS123477NINDS NIH HHS U01 NS106845NINDS NIH HHS U54 NS115052
6 · The paper itself

Abstract

backgroundRNA polymerase III-related or 4H leukodystrophy (POLR3-HLD) is an autosomal recessive hypomyelinating leukodystrophy characterized by neurological dysfunction, hypodontia and hypogonadotropic hypogonadism. The disease is caused by biallelic pathogenic variants in

methodsThe craniofacial features of 31 patients with POLR3-HLD were evaluated, and potential genotype-phenotype associations were evaluated.

resultsVarious craniofacial abnormalities were recognized in this patient cohort, with each individual presenting at least one craniofacial abnormality. The most frequently identified features included a flat midface (61.3%), a smooth philtrum (58.0%) and a pointed chin (51.6%). In patients with

conclusionThrough this study, we demonstrated that craniofacial abnormalities are common in patients with POLR3-HLD. This report describes in detail the dysmorphic features of POLR3-HLD associated with biallelic variants in

Indexed as

Demyelinating DiseasesNeurodegenerative DiseasesDNA-Directed RNA PolymerasesHumansInheritance PatternsRNA Polymerase IIIDNA-Directed RNA PolymerasesPOLR1C protein, humanPOLR3A protein, humanPOLR3B protein, humanRNA Polymerase IIIgeneticsgenetics, medicalneurodegenerative diseasesneurologypediatrics

Identifiers

PMID37197783
PMCPMC10579516
OpenAlexW4376876618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.